In our free oncology on-demand webinar learn how your study can deliver the most meaningful endpoint data.
Clario’s flexible and comprehensive range of digital endpoint solutions ensures we have the most appropriate approach for your trial. Our experts can help your drug stand out from the crowd by optimizing your strategy to demonstrate safety, efficacy, and impact on quality of life.
Achieve precise and reliable assessments with our advanced imaging solutions.
Improve accuracy and compliance with electronic patient and clinician-reported outcomes. Our Rapid Start solution expedites trial setup.
Implement oncology-specific strategies to assess QT prolongation risks, helping ensure patient safety and regulatory compliance.
Objectively measure mobility and sleep to distinguish your compound in a competitive market.
MORE THAN
65%
of all FDA new oncology drug approvals for biotechs supported since 2012
Clario partners with biotech companies to fine-tune their endpoint data strategies, implement the most appropriate data capture methodologies, and enable operational excellence for trial success.
Watch our webinar to learn more about our comprehensive trial support.
Receive expert guidance tailored to specific oncology indications, aligning endpoint strategies with global regulations.
Benefit from innovative data capture and analytics for seamless trial execution.
Gain access to Project Managers across timezones, dedicated to biotech companies and local and global logistics, enabling rapid trial scaling.
Watch our webinar to learn more about our comprehensive trial support.
Cardio-oncology
Gain insights into the unique challenges of demonstrating cardiac safety in oncology clinical trials.
Best practices and technologies
Enhance data quality without increasing patient burden across cardiac, imaging and ePROs.
Importance of PROs
Understand the latest FDA guidance for incorporating Patient-Reported Outcomes in oncology development.
Set your oncology clinical trial up for success. Watch our webinar to discover more about cardiac safety, imaging and eCOA for early phase trials!